XRCC5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.43159994759179E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.79330000036482E-07 |
Normal-vs-Stage2 |
6.33540000000155E-05 |
Normal-vs-Stage3 |
1.29110000468557E-08 |
Normal-vs-Stage4 |
2.04010000000032E-05 |
Stage1-vs-Stage2 |
3.160000E-01 |
Stage1-vs-Stage3 |
1.029680E-02 |
Stage1-vs-Stage4 |
2.616400E-01 |
Stage2-vs-Stage3 |
4.144000E-01 |
Stage2-vs-Stage4 |
9.443600E-01 |
Stage3-vs-Stage4 |
4.271000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.55239999743984E-08 |
Normal-vs-AfricanAmerican |
1.63074999999235E-05 |
Normal-vs-Asian |
1.333210E-01 |
Caucasian-vs-AfricanAmerican |
3.351600E-01 |
Caucasian-vs-Asian |
7.733600E-01 |
AfricanAmerican-vs-Asian |
5.316000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.76240022575769E-10 |
Normal-vs-Female |
1.210800E-04 |
Male-vs-Female |
3.963600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.675600E-03 |
Normal-vs-Age(41-60Yrs) |
3.31920000040675E-07 |
Normal-vs-Age(61-80Yrs) |
3.53110000128609E-08 |
Normal-vs-Age(81-100Yrs) |
2.419600E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.363000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.208400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.491000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.828800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.658850E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.051800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.559600E-01 |
Normal-vs-Grade 2 |
3.52559999999835E-05 |
Normal-vs-Grade 3 |
1.9549000196406E-09 |
Normal-vs-Grade 4 |
2.27260000040808E-07 |
Grade 1-vs-Grade 2 |
6.038400E-01 |
Grade 1-vs-Grade 3 |
1.334840E-01 |
Grade 1-vs-Grade 4 |
9.395600E-02 |
Grade 2-vs-Grade 3 |
6.124400E-03 |
Grade 2-vs-Grade 4 |
5.984600E-03 |
Grade 3-vs-Grade 4 |
4.078800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.411400E-04 |
Normal-vs-ccB subtype |
4.39859999534775E-08 |
ccA subtype-vs-ccB subtype |
8.230700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.14440000031912E-07 |
Normal-vs-N1 |
4.107500E-02 |
N0-vs-N1 |
7.490000E-01 |
|
|